The spectrum of subclinical best vitelliform macular dystrophy in subjects with mutations in BEST1 gene

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 7, 2011, Pages 4678-4684

  Querques, Giuseppe ^a   Zerbib, Jennyfer ^a,b   Santacroce, Rossana ^c   Margaglione, Maurizio ^c   Delphin, Nathalie ^b   Querques, Lea ^a   Rozet, Jean Michel ^b   Kaplan, Josseline ^b   Souied, Eric H ^a,d  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITY OF FOGGIA   (Italy)

^d Unite Fonctionnelle de Recherche Clinique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; AUTOFLUORESCENCE; BESTROPHIN 1 GENE; CHILD; CLINICAL ARTICLE; ELECTROOCULOGRAPHY; EYE FUNDUS; FEMALE; GENE; GENE MUTATION; HUMAN; MALE; OPHTHALMOSCOPY; PIGMENT EPITHELIUM; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINA MACULA VITELLIFORM DEGENERATION; SCHOOL CHILD; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL ACUITY; GENETICS; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PEDIGREE; PENETRANCE; POINT MUTATION;

BEST1 PROTEIN, HUMAN; CHLORIDE CHANNEL; EYE PROTEIN;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHLORIDE CHANNELS; ELECTROOCULOGRAPHY; EYE PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; OPHTHALMOSCOPY; PEDIGREE; PENETRANCE; POINT MUTATION; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITELLIFORM MACULAR DYSTROPHY; YOUNG ADULT;

EID: 80052323903     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6500     Document Type: Article

References (43)

1. Best F. Uber eine hereditare Maculaafektion; Beiträge zur Verergslehre. Zschr Augenheilk. 1905;13:199-212.
2. Stone EM, Nichols BE, Streb LM, et al. Genetic linkage of vitelliform macular degeneration Best's disease to chromosome 11q13. Nat Genet. 1992; 246-250.
3. Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet. 1998;19:241-247.
4. Sun H, Tsunenari T, Yau KW, Nathans J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A. 2002;99:4008-4013.
5. Nordstrom S, Barkman Y. Hereditary maculardegeneration (HMD) in 246 cases traced to one gene-source in central Sweden. Hereditas. 1977;84:163-176.
6. Deutman AF, Hoyng CB. Macular dystrophies. In: Ryan SJ, ed. Retina, 3rd ed. St Louis: Mosby, 2001;1210-1257.
7. Souied EH, Querques G, Coscas G, Soubrane G. Retinal degenerations and dystrophies. In: Saxena S, Meredith TA, eds. Optical Coherence Tomography in Retinal Diseases. New Delhi: Jaypee, 2005;221-250.
8. Mohler CW, Fine SL. Long-term evaluation of patients with Best's vitelliform dystrophy. Ophthalmology. 1981;88:688-692.
9. Deutman AF. Electro-oculography in families with vitelliform dystrophy of the fovea. Detection of the carrier state. Arch Ophthalmol. 1969;81:305-316.
10. Cross HE, Bard L. Electro-oculography in Best's macular dystrophy. Am J Ophthalmol. 1974;77:46-50.
11. Krill AE, Morse PA, Potts AM, Klien BA. Hereditary vitelliruptive macular degeneration. Am J Ophthalmol. 1966;61:1405-1415.
12. Godel V, Chaine G, Regenbogen L, Coscas G. Best's vitelliform macular dystrophy. Acta Ophthalmol Suppl. 1986;175:1-31.
13. Spaide RF, Noble K, Morgan A, Freund KB. Vitelliform macular dystrophy. Ophthalmology. 2006;113:1392-1400.
14. Querques G, Regenbogen M, Quijano C, Delphin N, Soubrane G, Souied EH. High definition optical coherence tomography features in vitelliform macular dystrophy. Am J Ophthalmol. 2008;146: 501-507.
15. Querques G, Regenbogen M, Soubrane G, Souied EH. High-resolution spectral domain optical coherence tomography findings in multifocal vitelliform macular dystrophy. Surv Ophthalmol. 2009;54:311-316.
16. Ferrara DC, Costa RA, Tsang S, Calucci D, Jorge R, Freund KB. Multimodal fundus imaging in Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2010;248:1377-1386.
17. Querques G, Zerbib J, Santacroce R, et al. Functional and clinical data of Best vitelliform macular dystrophy patients with mutations in BEST1 gene. Mol Vis. 2009;15:2960-2972.
18. Lotery AJ, Munier FL, Fishman GA, et al. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:1291-1296.
19. Kramer F, White K, Pauleikhoff D, et al. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet. 2000;8:286-292.
20. Wabbels B, Preising MN, Kretschmann U, Demmler A, Lorenz B. Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2006;244:1455-1466.
21. Weber BH, Walker D, Muller B. Molecular evidence for nonpenetrance in Best's disease. J Med Genet. 1994;31:388-392.
22. Marmorstein AD, Kinnick TR. Focus on molecules: bestrophin (Best-1). Exp Eye Res. 2006;85:423-424.
23. Renner AB, Tillack H, Kraus H, et al. Late onset is common in best macular dystrophy associated with VMD2 gene mutations. Ophthalmology. 2005;112:586-592.
24. Boon CJF, Klevering BJ, den Hollander AI, et al. Clinical and genetic heterogeneity in multifocal vitelliform dystrophy. Arch Ophthalmol. 2007;125:1100-1106.
25. Bakall B, Marknell T, Ingvast S, et al. The mutation spectrum of the bestrophin protein-functional implications. Hum Genet. 1999;104: 383-389.
26. Mullins RF, Oh KT, Heffron E, Hageman GS, Stone EM. Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation. Arch Ophthalmol. 2005;123:1588-1594.
27. Mullins RF, Kuehn MH, Faidley EA, Syed NA, Stone EM. Differential macular and peripheral expression of bestrophin in human eyes and its implication for best disease. Invest Ophthalmol Vis Sci. 2007;48:3372-3380.
28. Lacassagne E, Dhuez A, Rigaudière F, et al. Phenotypic variability in a French family with a novel mutation in the BEST1 gene causing multifocal best vitelliform macular dystrophy. Mol Vis. 2011;17:309-322.
29. Booij JC, Boon CJ, van Schooneveld MJ, et al. Course of visual decline in relation to the Best1 genotype in vitelliform macular dystrophy. Ophthalmology. 2010;117:1415-1422.
30. Meunier I, Sénéchal A, Dhaenens CM, et al. Systematic screening of BEST1 and PRPH2 in juvenile and adult vitelliform macular dystrophies: a rationale for molecular analysis. Ophthalmology [Epub ahead of print].
31. Schatz P, Bitner H, Sander B, et al. Evaluation of macular structure and function by OCT and electrophysiology in patients with vitelliform macular dystrophy due to mutations in BEST1. Invest Ophthalmol Vis Sci. 2010;51:4754-4765.
32. Boon CJ, Theelen T, Hoefsloot EH, et al. Clinical and molecular genetic analysis of best vitelliform macular dystrophy. Retina. 2009;29:835-847.
33. Arnold JJ, Sarks JP, Killingsworth MC, et al. Adult vitelliform macular degeneration: a clinicopathological study. Eye. 2003;17: 717-726.
34. Boon CJF, den Hollander AI, Hoyng CB, Cremers FPM, Klevering BJ, Keunen JEE. The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene. Prog Retin Eye Res. 2008;27:213-235.
35. Maruko I, Iida T, Spaide RF, Kishi S. Indocyanine green angiography abnormality of the periphery in vitelliform macular dystrophy. Am J Ophthalmol. 2006;141:976-978.
36. Miller SA. Multifocal Best's vitelliform dystrophy. Arch Ophthalmol. 1977;95:984-990.
37. Burgess R, Millar ID, Leroy BP, et al. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet. 2008;82:19-31.
38. Schatz P, Ponjavic V, Andréasson S, Dahl N. Variant phenotype of Best vitelliform macular dystrophy associated with compound heterozygous mutations in VMD2. Ophthalmic Genet. 2006;27: 51-56.
39. Xiao Q, Yu K, Cui YY, Hartzell HC. Dysregulation of human bestrophin-1 by ceramideinduced dephosphorylation. J Physiol. 2009;587:4379-4391.
40. Sohrab MA, Allikmets R, Guarnaccia MM, Smith RT. Preimplantation genetic diagnosis for Stargardt disease. Am J Ophthalmol. 2010;149:651-655.
41. Allikmets R, Seddon JM, Bernstein PS, et al. Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies. Hum Genet. 1999;104:449-453.
42. Krämer F, Mohr N, Kellner U, Rudolph G, Weber BH. Ten novel mutations in VMD2 associated with Best macular dystrophy (BMD). Hum Mutat. 2003;22:418.
43. Yardley J, Leroy BP, Hart-Holden N, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci. 2004;45:3683-3689.